splice variant of extracellular matrix proteins(3B Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namesplice variant of extracellular matrix proteins(3B Pharmaceuticals)
Drug Alias Nameradioimmunotherapeutic/diagnostic imaging agent(3B Pharmaceuticals)
ClassificationBiologics > Protein drugs > Recombinant polypeptideRadiation-emitting products
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies3B Pharmaceuticals GmbH
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A